• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Alkem Laboratories Ltd.
    22 Sep 2025, 08:30PM
    Analyst Buy
    5544.00
    0.89%
    Alkem launches pertuzumab biosimilar
    Business Line
    Access to pertuzumab in India has remained restricted to limited HER2-postive breast cancer patients due to cost barriers, said the company
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
    Alkem launches pertuzumab biosimilar for breast cancer in India
    Business Standard | 22 Sep 2025, 08:07PM
    logo
    Dr. Reddy's Laboratories Ltd.
    22 Sep 2025, 07:19PM
    1307.00
    0.43%
    Dr Reddy's biosimilar gets nod from European Medical Agency's panel
    Business Line
    As part of the established approval process, the CHMP positive opinion will now be reviewed by the European Commission
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Hikal Ltd.
    22 Sep 2025, 05:21PM
    260.00
    -1.10%
    Baba's son Amit seeks re-election in Hikal amid family dispute
    Business Line
    Baba and his family own 34 per cent stake in Hikal while Hiremaths hold 35 per cent stake
    Copy LinkShare onShare on Share on Share on
    Hikal Ltd. has lost -36.65% in the last 6 Months
    logo
    Wockhardt Ltd.
    22 Sep 2025, 02:58PM
    1477.30
    -0.26%
    Indian drugmakers gear up for 600-800 cr insulin pen market post-Novo exit
    Business Standard
    Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore market opportunity from FY26 onwards
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. has an average target of 1870.00 from 1 broker.
    logo
    Lupin Ltd.
    20 Sep 2025
    US FDA Observation
    2007.50
    0.15%
    Lupin's Pune Facility Gets Four Observations After US FDA Inspection
    Lupin's Pune Facility Gets Four Observations After US FDA Inspection
    NDTV Profit
    The US FDA conducted a product-specific pre-approval inspection at the company's Pune biotech facility from Sept. 8 to Sept. 19, according to an exchange filing.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below its 200 day SMA of 2025.5
    logo
    Ajanta Pharma Ltd.
    19 Sep 2025
    2541.50
    0.09%
    Broker's call: Ajanta Pharma (Buy)
    Business Line
    PL Capital
    Copy LinkShare onShare on Share on Share on
    Ajanta Pharma Ltd. has an average target of 3022.00 from 5 brokers.
    logo
    Aurobindo Pharma Ltd.
    19 Sep 2025
    1109.20
    -0.73%
    Fire at Aurobindo Pharma's subsidiary unit in AP
    Business Line
    Mishap at APL healthcare's Naidupeta in AP caused temporary disruption of produciton
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
    logo
    Laurus Labs Ltd.
    19 Sep 2025
    910.85
    0.78%
    Laurus Labs soars 6% in 2 days, market cap tops 50,000 crore; here's why
    Business Standard
    At 11:29 AM, Laurus Labs' stock was quoting 2 per cent higher at 943.15 on the BSE, commanding an m-cap of 50,913 crore, exchange data shows
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 39.92% in the last 3 Months
    logo
    Unichem Laboratories Ltd.
    19 Sep 2025
    495.50
    0.72%
    Unichem Labs shares drop 5% on 19.49-mn notice from European Commission
    Business Standard
    Unichem Laboratories' stock fell 5 per cent after a demand notice from the European Commission for a fine of Euro 19.49 million
    Copy LinkShare onShare on Share on Share on
    Unichem Laboratories Ltd. has lost -30.18% in the last 6 Months
    logo
    Natco Pharma Ltd.
    18 Sep 2025
    854.50
    -1.16%
    Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI
    Business Standard
    Natco Pharma stock was trading at 884.5, up 3.2 per cent compared to the previous session's close of 857.25 on the NSE
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd.'s price crossed below 30Day SMA today
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • GK Energy
    • Siddhi Cotspin
    • Saatvik Green Energy
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd